Who owns the SEROX trademark?

The SEROX trademark is owned by Pathogen Dx, Inc..

What class is the SEROX trademark registered in?

The SEROX trademark is registered in Class 009 (Electronics, software & scientific instruments).

What is the serial number for SEROX?

The USPTO serial number for SEROX is 97802398.

What is the registration number for SEROX?

SEROX is registered under USPTO registration number 7852435.

SER

USPTO Trademark Record

REGISTERED

SEROX

SN 97802398·Reg 7852435·Filed Feb 20, 2023

Owner Pathogen Dx, Inc.

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable multimedia files, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus.

SEROX (Serial No. 97802398), Registration No. 7852435, is a registered US trademark filed on Feb 20, 2023 by Pathogen Dx, Inc.. This trademark covers Class 009 (Electronics, software & scientific instruments).

early section 8: July 01, 2031

Mark Intelligence

SEROX (Reg. #7852435) is a registered US trademark that has been protecting its owner, Pathogen Dx, Inc., since 2023. The mark covers Class 009 (Electronics, software & scientific instruments). Goods and services include Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, s.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 20, 2023

SERIAL

97802398

REG#

7852435

REGISTERED

Jul 01, 2025

Owner

Applicant

Pathogen Dx, Inc.

Entity

Corporation

State

Address

9375 E. Shea Blvd, Suite 100, Scottsdale, AZ, 85260

Country

Attorney

NameDR BENJAMIN ADLER

Law firm

DR BENJAMIN ADLER ADLER & ASSOCIATES

Docket

D7954

Address

POB 710509, HOUSTON, TX 77271, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 20, 2023

Serial Number97802398

Registration No.7852435

Registration DateJul 01, 2025

Status DateJul 01, 2025

Published for OppositionSep 12, 2023

Mark TypeStylized characters

Attorney DocketD7954

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 009Electronics, software & scientific instruments

US codes: 021, 023, 026, 036, 038

First use anywhere: Dec 13, 2024

First use in commerce: Dec 13, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

44 events

REGISTERED-PRINCIPAL REGISTER

Jul 01, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 01, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 09, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 09, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 12, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

May 09, 2025

SOU EXTENSION 3 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

May 09, 2025

STATEMENT OF USE PROCESSING COMPLETE

SOU TEAS EXTENSION RECEIVED

May 05, 2025

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

May 05, 2025

TEAS STATEMENT OF USE RECEIVED

SOU EXTENSION 3 FILED

May 05, 2025

SOU EXTENSION 3 FILED

USE AMENDMENT FILED

May 05, 2025

USE AMENDMENT FILED

SOU EXTENSION 2 GRANTED

Dec 12, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 12, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

ABANDONMENT - NO USE STATEMENT FILED

Dec 09, 2024

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 09, 2024

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

TEAS PETITION TO REVIVE RECEIVED

Dec 09, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Dec 09, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Dec 09, 2024

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Dec 09, 2024

SOU EXTENSION RECEIVED WITH TEAS PETITION

SOU EXTENSION 2 FILED

Nov 07, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 1 GRANTED

Oct 03, 2024

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 03, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 02, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS PETITION TO REVIVE RECEIVED

Jul 16, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Jul 16, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Jul 16, 2024

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Jul 16, 2024

SOU EXTENSION RECEIVED WITH TEAS PETITION

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jul 12, 2024

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Jun 10, 2024

ABANDONMENT - NO USE STATEMENT FILED

SOU EXTENSION 1 FILED

May 07, 2024

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 07, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 12, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 12, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 23, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 04, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 31, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 30, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 30, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

May 22, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 22, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 22, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 12, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 09, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 23, 2023

NEW APPLICATION ENTERED

SEROX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Pathogen Dx, Inc.

Other Marks by DR BENJAMIN ADLER

Resources

Company